Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obesity.

Anthony N Fabricatore1, Thomas A Wadden

  • 1University of Pennsylvania, School of Medicine, Department of Psychiatry, Weight and Eating Disorders Program, Philadelphia, Pennsylvania 19104-3309, USA. fabricat@mail.med.upenn.edu

Annual Review of Clinical Psychology
|August 25, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short- and long-term effects of semaglutide 2.4 mg on energy intake, appetite, and food reward: a 60-week, double-blind randomized controlled trial.

The American journal of clinical nutrition·2026
Same author

Lifestyle Modification and Incretin-Based Therapy for Obesity.

JAMA·2026
Same author

Use of Naltrexone-Bupropion in Persons With Overweight/Obesity and Symptoms of Depression: A Pooled Analysis.

Obesity (Silver Spring, Md.)·2026
Same author

Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT.

Obesity (Silver Spring, Md.)·2026
Same author

Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety.

PLoS medicine·2026
Same author

Internalized weight stigma, metabolic syndrome, and inflammation in postmenopausal women with obesity.

Brain, behavior, & immunity - health·2025

Obesity prevalence is rising, yet nonsurgical treatments show minimal weight loss. However, even modest weight loss significantly improves obesity-related health issues and comorbidities.

Area of Science:

  • Public Health
  • Endocrinology
  • Metabolic Disorders

Background:

  • Rising global obesity rates necessitate research into causes, associated conditions, and effective interventions.
  • Current nonsurgical obesity treatments have yielded limited long-term weight loss over two decades.
  • Obesity is linked to numerous serious health conditions and mental health challenges like depression.

Purpose of the Study:

  • To define obesity and outline its associated disease conditions.
  • To review current treatment options for obesity, including behavioral, pharmacological, and surgical approaches.
  • To examine the relationship between obesity and depression and identify future research and prevention strategies.

Main Methods:

  • Literature review of obesity etiology, comorbidities, and treatment outcomes.

Related Experiment Videos

  • Analysis of data on weight loss achieved through various therapeutic interventions.
  • Examination of studies investigating the link between obesity and depression.

    • Main Results:

    • Nonsurgical obesity treatments have shown little improvement in mean weight loss over 20 years.
    • Modest weight reduction through available therapies significantly improves obesity-related health problems.
    • Bariatric surgery offers substantial weight loss and can lead to remission of comorbid conditions.

    Conclusions:

    • Despite limited weight loss from nonsurgical methods, their health benefits are significant.
    • Bariatric surgery is a highly effective treatment for severe obesity and associated comorbidities.
    • Further research into obesity prevention and the obesity-depression link is crucial.